Chartwell Pharmaceuticals operates four manufacturing and analytical campuses in the New York metropolitan area, developing and producing generic prescription medicines in a broad range of dosage forms. With a leadership team whose members bring more than 20 years of generic-pharmaceutical experience apiece, the company handles work from formulation trials and clinical supplies through commercial production in fully cGMP-compliant facilities. Its U.S.-made portfolio includes more than 1,100 FDA-approved Orange Book listings and products compliant with the Trade Agreements Act and Buy American Act.
Current Good Manufacturing Practice (cGMP)
compliance_program
Trade Agreements Act (TAA) Compliant Production
compliance_program
Buy American Act (BAA) Compliant Products
compliance_program